Premium
The C. elegans P4‐ATPase TAT‐1 Regulates Lysosome Biogenesis and Endocytosis
Author(s) -
Ruaud AnneFrançoise,
Nilsson Lars,
Richard Fabrice,
Larsen Morten Krog,
Bessereau JeanLouis,
Tuck Simon
Publication year - 2009
Publication title -
traffic
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.677
H-Index - 130
eISSN - 1600-0854
pISSN - 1398-9219
DOI - 10.1111/j.1600-0854.2008.00844.x
Subject(s) - biology , microbiology and biotechnology , endocytosis , endosome , lysosome , vacuole , v atpase , escrt , effector , atpase , intracellular , biochemistry , cell , cytoplasm , enzyme
P‐type adenosine triphosphatases (ATPases) of the Drs2p family (P4‐ATPases) are multipass transmembrane proteins required to generate and maintain phospholipid asymmetry in membrane bilayers. In Saccharomyces cerevisiae , several members of this family control distinct transport events within the endosomal and secretory pathways. Comparatively, little is known about the functions of P4‐ATPases in multicellular organisms. In this study, we analyzed the role of the Caenorhabditis elegans Drs2p homologue transbilayer amphipath transporter (TAT)‐1 in intracellular trafficking. tat‐1 is expressed in many tissues including the intestine, the epidermis and the nervous system. In intestinal cells, tat‐1 loss‐of‐function mutants accumulate large vacuoles of mixed endolysosomal identity positive for the lysosomal protein LMP‐1. In addition, they lack the same class of storage granules as lmp‐1 mutants, suggesting that part of the tat‐1 phenotype might result from LMP‐1 sequestration in an aberrant compartment. Epidermal cells mutant for tat‐1 contain acidified giant hybrid multivesicular bodies probably corresponding to endolysosomal intermediate compartments or deficient lysosomes. Finally, TAT‐1 is required for yolk uptake in oocytes and an early step of fluid‐phase endocytosis in the intestine. Hence, TAT‐1 is required at multiple steps of the endolysosomal pathway, at least in part by ensuring proper trafficking of cell‐specific effector proteins.